Substituted Piperidine CXCR4 Inhibitors for Tumor Microenvironment Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant unmet need for effective CXCR4 inhibitors to treat diseases and conditions mediated by aberrant or undesired expression of the C-X-C chemokine receptor type 4 (CXCR4), particularly in cellular proliferative disorders such as cancer, as existing modulators like condensed azines have limitations.
Innovation Solution
Development of compounds and pharmaceutically acceptable compositions that inhibit CXCR4 activity, including specific substituted piperidines and their salts, which can be used to treat various disorders associated with CXCR4.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used to target CXCR4, then treatment of CXCR4-mediated diseases is attempted, but the effectiveness is insufficient due to challenges in targeting the receptor
Solution Approach 1:
The patent employs parameter changes by modifying the chemical structure of piperidine compounds to optimize their binding affinity and selectivity for CXCR4. Specific substitutions at different positions on the piperidine ring (R1, R2, R3, R4, R5, R6) are systematically varied to improve inhibitory potency while maintaining drug-like properties, thereby enhancing the reliability of CXCR4 targeting.
Solution Approach 2:
The invention applies local quality by introducing specific functional groups and substituents at particular positions on the piperidine core structure. Each substitution (e.g., aryl groups at R1, alkyl chains at R2-R6) is strategically placed to interact with specific residues in the CXCR4 binding pocket, thereby improving the precision and effectiveness of receptor targeting.
2Reliability
If CXCR4 inhibitors are developed to treat cancer, then tumor burden may be reduced, but the complexity of the chemical compounds increases
Solution Approach 1:
The patent achieves universality by designing a piperidine-based scaffold that can serve multiple therapeutic functions. The core piperidine structure with specific substitution patterns provides both CXCR4 inhibition and favorable pharmacokinetic properties, allowing a single compound to address multiple aspects of cancer therapy including tumor growth inhibition and potential metastasis prevention.
Solution Approach 2:
The invention applies composite materials by combining the piperidine core with various aromatic rings, alkyl chains, and functional groups to create complex but optimized molecular structures. These composite molecular architectures integrate multiple functional elements that work synergistically to achieve potent CXCR4 inhibition while maintaining drug-like properties.
Data Source
AI summary
The present invention relates to substituted piperidines useful for inhibition of C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and compositions for use in methods of using said compositions in the treatment of various disorders.